Samsrita Labs, a company in the Healthcare Service Provider industry, reported revenue of ₹0.02 crore and a net loss of ₹0.48 crore for the March 2026 quarter.
Samsrita Labs (BSE: SAMSRITA) closed at ₹11.50 on 20 Nov 2026, down 48.0% over the past year. Its market capitalisation is ₹26 crore.
Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.